The biggest risk is not that the product stops mattering; it is that Symbotic stays operationally strong but financially bottlenecked by one customer, lumpy acceptance timing, and a lingering trust
discount from control weaknesses. Because the stock already carries a
premium valuation, even decent operating progress may not be enough unless diversification, deployment throughput, and reporting credibility all improve together.